Physician

Aamir Rasheed, MD

According to 2025 Medicare claims, Aamir Rasheed, MD (NPI: 1568547933) practices neurology in the Binghamton, NY market, with the plurality of this provider's patient population coming from Broome, NY. This provider's primary affiliated billing organization is NEURO MEDICAL CARE ASSOCIATES PLLC (NPI: 1447335757; TIN: 161602141) and primary practice location at 13850-1559.

Rasheed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 518 traditional Medicare patients, billed 912 HCPCS/CPT codes, and received $90,663 in Medicare payments. The top billing code was 95813 (Measurement of brain wave activity (eeg), 61-119 minutes). Part D data shows 5,420 prescription claims across 799 beneficiaries totaling $3,943,208 in drug costs, led by Rebif (Interferon Beta-1a/Albumin). 2021 DME data shows 12 claims. Open Payments data shows 169 records totaling $9,636. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $194,152 to $90,663. In contrast, Part D prescription costs have risen steadily, from $2,488,904 to $3,943,208. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	824	10,127	$194,152
2016	899	8,770	$209,341
2017	837	9,822	$182,597
2018	837	1,898	$149,099
2019	877	1,842	$146,558
2020	739	1,627	$118,031
2021	703	1,392	$139,203
2022	665	1,097	$117,113
2023	566	907	$90,806
2024	518	912	$90,663

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	606	5,736	$2,488,904
2016	642	5,826	$2,676,955
2017	674	6,300	$3,128,291
2018	706	6,026	$3,214,359
2019	744	5,584	$3,512,626
2020	785	5,634	$4,257,685
2021	862	6,064	$4,449,312
2022	860	6,148	$4,477,060
2023	798	5,604	$4,104,958
2024	799	5,420	$3,943,208

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	11	11	$1,083
2017	15	16	$1,126
2018	11	11	$986
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$2,173
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95813	Measurement of brain wave activity (eeg), 61-119 minutes	44	45	$341
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	63	63	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	127	147	$89
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	103	194	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	241	257	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rebif	Interferon Beta-1a/Albumin	53	1,708	$639,978
Copaxone	Glatiramer Acetate	41	1,788	$365,616
Aubagio	Teriflunomide	23	1,110	$329,360
Rebif Rebidose	Interferon Beta-1a/Albumin	23	672	$243,645
Tecfidera	Dimethyl Fumarate	17	630	$186,844

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	169	$9,636	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aamir Rasheed, MD?

Tedicare shows public-source Medicare data for Aamir Rasheed, MD (NPI 1568547933), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aamir Rasheed, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aamir Rasheed, MD?

Aamir Rasheed, MD is linked to NEURO MEDICAL CARE ASSOCIATES PLLC (billing NPI 1447335757) in the available physician profile data.

Does Aamir Rasheed, MD have Open Payments data?

Aamir Rasheed, MD has 169 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.